[1] Klahr, S. (1999) The Geriatric Patient with Obstructive Uropathy. Geriatric Nephrology and Urology, 9, 101-107.
http://dx.doi.org/10.1023/A:1008387116491
[2] Gulmi, F.A., Felson, D. and Vaughan, E.D. (1998) The Pathophysiology of Urinary Tract Diseases. Campbells Urology, 342-385.
[3] Murnaghan, G.F. (1958) The Dynamics of the Renal Pelvis and Ureter with Reference to Congenital Hydronephrosis. British Journal of Urology, 30, 321-324.
http://dx.doi.org/10.1111/j.1464-410X.1958.tb03525.x
[4] Hanna, J.K. (2000) Antenatal Hydronephrosis and Ureteropelvic Junction Obstruction: The Case for Early Intervention. Urology, 55, 612-615.
http://dx.doi.org/10.1016/S0090-4295(00)00460-X
[5] Jara, H., Barish, E.K., Yucel, E.R., Melhem, S., Hussain, J. and Ferrucci, T. (1998) MR Hydrography. Theory and Practice of Static Fluid Imaging. American Journal of Roentgenology, 170, 873-882.
http://dx.doi.org/10.2214/ajr.170.4.9530026
[6] Lauterber, P.C. (1973) Image Formation by Induced Local Interaction: Examples of Employing Nuclear Magnetic Resinanace. Nature, 242, 190-191.
http://dx.doi.org/10.1038/242190a0
[7] O’Malley, M.E., Soto, J.A., Yucel, E.K. and Hussain, S. (1997) MR Urography: Evaluation of a Three-Dimensional Fast Spin-Echo Technique in Patients with Hydronephrosis. American Journal of Roentgenology, 168, 387-392.
http://dx.doi.org/10.2214/ajr.168.2.9016213
[8] Bassignani, M.J. (2006) Understanding and Interpreting MRI of the Genito-Urinary Tract. Urologic Clinics of North America, 33, 135-151.
[9] Valtuille, G.R., Ai-Valtuille, G., Abascal, F., Cerezal, L. and Arguello, M.C. (2006) Magnetic Resonance Urography: A Pictorial Overview. British Journal of Radiology, 79, 614-626.
http://dx.doi.org/10.1259/bjr/21075982
[10] Murphy, K.J., Brunberg, J.A. and Cohan, R.H. (1996) Adverse Reactions to Gadolinium Contrast Media: A Review of 36 Cases. American Journal of Roentgenology, 167, 847-849.
http://dx.doi.org/10.2214/ajr.167.4.8819369
[11] Runge, V.M. (2001) Safety of Magnetic Resonance Contrast Media. Topics in Magnetic Resonance Imaging, 12, 309-314.
http://dx.doi.org/10.1097/00002142-200108000-00007
[12] Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M.B., Heaf, J.G., et al. (2006) Nephrogenic Systemic Fibrosis: Suspected Etioliogy Role of Gadodiamide Used for Contrast Enhanced MRIJ. American Society of Nephrology, 17, 2359-2362.
[13] Grobner, T. (2006) Gadolinium—A Specific Trigger for the Development of Nephrogenic Systemic Fibrosis. Nephrology Dialysis Transplantation, 21, 1104-1108.
http://dx.doi.org/10.1093/ndt/gfk062
[14] Katzberg, R.W., Buonocore, M.H., Ivanovic, M., et al. (2001) Functional, Dynamic, and Anatomic MR Urography: Feasibility and Preliminary Findings. Academic Radiology, 8, 1083-1099.
http://dx.doi.org/10.1016/S1076-6332(03)80720-1
[15] Martin, X. and Rouvière, O. (2001) Radiologic Evaluations Affecting Surgical Technique in Ureteropelvic Junction Obstruction. Current Opinion in Urology, 11, 193-196.
http://dx.doi.org/10.1097/00042307-200103000-00011
[16] Zamparelli, M., Cobellis, G., Rossi, L., Valeri, G., Amici, G. and Martino, A. (2003) Detection of Crossing Vessels at the Ureteropelvic Junction with Fast MRI. Pediatria Medica e Chirurgica, 25, 50-52.
[17] Shokeir, A.A., El-Diasty, T.A., Eassa, W., Mosbah, A., El-Ghar, M.A., Mansour, O., et al. (2004) Diagnosis of Ureteral Obstruction in Patients with Compromised Renal Function: The Role of Noninvasive Imaging Modalities. Journal of Urology, 171, 2303-2306.
http://dx.doi.org/10.1097/01.ju.0000124928.69055.10
[18] Public Health Advisory: Gadolinium Containing Contrast Agents for Magnetic Resonance Imaging: Omniscan, OptiMARK, Magnevest, Prohance and Multihance. US Food and Drug Administration, Centre for Drug Evaluation and Research.
www.fda.gov/cder/advisory/gadolinium.agents.htm
[19] El-Diasty, T., Mansour, O. and Farouk, A. (2003) Diuretic Contrast-Enhanced Magnetic Resonance Urography versus Intravenous Urography for Depiction of Nondilated Urinary Tracts. Abdominal Imaging, 28, 135-145.
http://dx.doi.org/10.1007/s00261-002-0010-x
[20] Wolf, G.L., Hoop, B., Cannillo, J.A., Rogowska, J.A. and Halpern, E.F. (1994) Measurement of Renal Transit of Gadopentate Dimeglumine with Echo-Planar MR Imaging. Journal of Magnetic Resonance Imaging, 4, 365-372.
http://dx.doi.org/10.1002/jmri.1880040323
[21] Nortier, J. and del Marmol, V. (2007) Nephrogenis Systemic Fibrosis—The Need for a Multidisciplinary Approach. Nephrology Dialysis Transplantation, 22, 3097-3101.
http://dx.doi.org/10.1093/ndt/gfm430
[22] Baron, P.W., Cantos, K., Hillebrand, D.J., Hu, K.Q., Ojogho, O.N., Nehlsen-Cannarella, S., et al. (2003) Nephrogenic Fibrosing Dermopathy after Livertransplantion Successfully Treated with Plasmopheresis. American Journal of Dermatopathology, 25, 204-209.
http://dx.doi.org/10.1097/00000372-200306000-00004